NCT00226590View on ClinicalTrials.gov

Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Lung Cancer
Interventions
DRUG

Gemcitabine

Induction Chemotherapy.

DRUG

Carboplatin

Induction Chemotherapy. Weekly Carboplatin and Paclitaxel During Thoracic Radiation Therapy.

DRUG

Paclitaxel

Weekly Carboplatin and Paclitaxel During Thoracic Radiation Therapy.

PROCEDURE

Radiation

Radiation Therapy will begin on day 57 if there has been adequate hematologic recovery from Induction Chemotherapy.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center & Research Insitute, Tampa

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00226590 - Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | Biotech Hunter | Biotech Hunter